TMDX241220P135000
- 54.46
- 0.000.00%
TransMedics Newsroom
Needham Downgrades TransMedics(TMDX.US) to Hold Rating
TransMedics Group Price Target Maintained With a $109.00/Share by Needham
Oppenheimer Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $125
TransMedics Group (TMDX) Gets a Buy From Oppenheimer
TransMedics Group Is Maintained at Buy by Canaccord Genuity
CCORF Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $104
Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $110
TransMedics Gr Analyst Ratings
TD Cowen Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $120
Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $180
Morgan Stanley Maintains TransMedics(TMDX.US) With Hold Rating, Cuts Target Price to $87
Morgan Stanley Sticks to Their Hold Rating for TransMedics Group (TMDX)
TD Cowen Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $175
Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $180
A Quick Look at Today's Ratings for TransMedics(TMDX.US), With a Forecast Between $150 to $180
TransMedics Group Price Target Cut to $109.00/Share From $169.00 by Canaccord Genuity
TransMedics Group Is Maintained at Outperform by Baird
TransMedics Gr Analyst Ratings
Needham Maintains Buy on TransMedics Gr, Lowers Price Target to $109
TD Cowen Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $175